CONNECT WITH US

Qisda-backed Elixiron tackles Alzheimer's with new drug developments

Rebecca Kuo, Taipei; Kevin Wang, DIGITIMES Asia 0

Credit: DIGITIMES

Biotechnology firm Elixiron Immunotherapeutics is the only company in Asia to have twice received "Part the Cloud" grants sponsored by the US-based Alzheimer's Association and Bill Gates, securing roughly NT$60 million (US$1.9 million) in non-dilutive...

The article requires paid subscription. Subscribe Now